Related Experiment Video
Updated: Jan 10, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Cataract in children with type 1 diabetes: a single-center experience from North India on an underrecognized
Devi Dayal1, Soumya Jyoti Raha2, Sayan Banerjee1
1Department of Pediatrics, Pediatric Endocrinology and Diabetes Unit, 29751 Post Graduate Institute of Medical Education and Research , Chandigarh, India.
Insights
Cataracts affect over 1% of children with type 1 diabetes (T1D), often appearing early. Early screening at diagnosis and within the first year is crucial for managing this complication.
Area of Science:
- Ophthalmology
- Pediatric Endocrinology
- Diabetology
Background:
- Cataract screening is recommended for children with type 1 diabetes (T1D).
- Limited data exists on cataract prevalence and associated factors in resource-limited settings.
Purpose of the Study:
- To evaluate the prevalence of cataracts in children with T1D.
- To identify factors associated with cataract development in this population.
Main Methods:
- Retrospective, hospital-based observational study in North India.
- Analysis of clinical, anthropometric, biochemical, and ophthalmologic data of T1D children with cataracts (2015-2025).
Main Results:
- Cataracts developed in 1.18% of 1776 T1D children.
- 14.2% had cataracts at diabetes diagnosis; 28.6% developed early cataracts.
- Mauriac syndrome was present in 38.1% of cases; negative correlation between HbA1c and cataract onset interval (r=-0.468, p=0.032).
Conclusions:
- Cataracts in T1D children can manifest early, potentially linked to metabolic control or autoimmune factors.
- Screening at diagnosis and within the first year is recommended.
- Region-specific guidelines are needed for early detection and management.
Objectives:
Consensus guidelines recommend cataract screening, along with a comprehensive eye evaluation, based on symptoms or at the time of screening for retinopathy in type 1 diabetes (T1D). This study evaluated the prevalence of cataract in T1D children and factors associated with it in resource-limited settings.
Methods:
We conducted a retrospective, hospital-based observational study at a tertiary care center in North India, analyzing children with T1D who developed cataracts between April 2015 and March 2025. Clinical, anthropometric, biochemical, and ophthalmologic data were extracted from medical records.
Results:
Of 1776 children diagnosed with T1D in the study period, 21 (1.18 %) developed cataracts. The median age at diabetes diagnosis was 7.7 years, and cataract diagnosis occurred at a median age of 9.9 years. Bilateral involvement was universal. Cataracts were present at the time of diagnosis of diabetes in 14.2 % and developed within the first year (early cataract) in 28.6 %. Posterior subcapsular cataract was the most common morphology. Notably, 38.1 % had Mauriac syndrome, all of whom developed cataracts later in the disease course, with significantly lower c-peptide levels. A strong negative correlation existed between baseline HbA1c and cataract onset interval (r=-0.468, p=0.032). Six children improved with glycemic control alone, while 10 underwent surgery.
Conclusion:
Cataracts in children with T1D can occur early and may reflect poor metabolic control or autoimmune triggers. Screening should be considered at diagnosis and within the first year. Our findings underscore the need for region-specific guidelines to facilitate early detection and management of this vision-threatening yet treatable complication.
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Angle Closure Glaucoma: Treatment
Diabetes: Symptoms, Diagnosis, and Complications
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

